香港股市 將在 14 分鐘 開市

京東健康 (6618.HK)

HKSE - HKSE 延遲價格。貨幣為 HKD。
加入追蹤清單
65.800+2.650 (+4.20%)
收市價: 09:01AM HKT

京東健康

Building C, 8th Floor
No. 18 Kechuang 11 Street Yizhuang Eco & Tech Dev Zn Daxing District
Beijing 101111
China

http://ir.jdhealth.com

版塊Healthcare
行業Medical Care Facilities
全職員工2,576

高階主管

名稱標題支付行使價出生年份
Mr. Enlin JinCEO & Exec. Director1980
截止 為止計算的金額,現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 HKD。

描述

JD Health International Inc., an investment holding company, operates an online healthcare platform in the People's Republic of China. It offers pharmaceutical and healthcare products, including OTC drugs, prescription drugs, and medical devices and supplies, as well as health and wellness products through direct selling and online retail pharmacy network. The company also provides online healthcare services, such as online consultation, prescription renewal, chronic disease management, family doctor, and consumer healthcare services; health management and intelligent healthcare solutions, as well as technical and advertising services. In addition, its platform allows users to book appointments and pay for services, such as general physical exams, aesthetic medicines, vaccination appointments, dental care services, and nucleic acid testing tests. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.

公司管治

截至 無 止,京東健康 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中:無;董事會:無;股東權利:無;現金賠償:無。

企業管治評分的資料提供: Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險,而 10 分表示較高的管治風險。